CSL (CSLLY) News Today → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free CSLLY Stock Alerts $90.16 +0.06 (+0.07%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCSL Stock Earnings: Carlisle Companies Beats EPS, Beats Revenue for Q1 2024investorplace.com - April 25 at 10:03 PMCSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathyprnewswire.com - April 24 at 3:00 AMArtelo Biosciences (NASDAQ:ARTL) versus CSL (OTCMKTS:CSLLY) Financial Reviewamericanbankingnews.com - April 17 at 1:44 AMHow much do you need to invest in CSL shares for $8,000 in annual dividends?msn.com - April 16 at 11:00 PMUBS Sticks to Their Buy Rating for CSL (CMXHF)markets.businessinsider.com - April 12 at 8:18 AMMacquarie brokers say CSL is heading to $500 per shareafr.com - April 9 at 12:39 AMCSLR Stock Earnings: Complete Solaria Beats EPS, Misses Revenue for Q4 2023investorplace.com - April 5 at 8:03 AMAkebia Therapeutics Surges on FDA Approval for Anemia Treatment (CSLLY)marketbeat.com - April 3 at 3:04 PMOwn CSL shares? You're receiving a healthy dividend boost today!fool.com.au - April 2 at 7:28 PMVafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patientsfinance.yahoo.com - March 28 at 7:42 AMBlood giant CSL works up $US1 billion-plus bond deal; banks mandatedafr.com - March 26 at 4:51 AMCSL Ltd's Dividend Analysisfinance.yahoo.com - March 11 at 8:47 AMCSL Seqirus is Fully Prepared to Implement the FDA's Vaccines and Related Biological Products Advisory Committee Trivalent Influenza Vaccines Strain Selection for the 2024/25 U.S. Seasonprnewswire.com - March 6 at 9:00 AMWilsons downgrades CSL (CMXHF) to a Holdmarkets.businessinsider.com - February 15 at 7:16 AMCSL shares tumble despite first-half earnings beatfool.com.au - February 13 at 8:13 AMWhat we learnt from CSL, Challenger, Seek and Breville’s resultsafr.com - February 13 at 12:22 AMCSL Limited: Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³finanznachrichten.de - February 13 at 12:22 AMCSL share price on watch amid 20% profit jumpfool.com.au - February 12 at 7:22 PMCSL Says 1H Profit Rises, Boosts Dividend -- Updatemarketwatch.com - February 12 at 7:22 PMCSL shrugs off trial setback to post double-digit earnings growthafr.com - February 12 at 7:22 PMCSL Profit Rises, Boosts Dividendwsj.com - February 12 at 7:22 PMCSL Limited falls after Phase 3 setback for key trialmsn.com - February 12 at 2:21 PMAsian stocks move little in holiday-thinned trade; CSL drags on Australiamsn.com - February 12 at 12:24 AMCSL and Arcturus’ Covid-19 booster found to prolong immunitymsn.com - February 6 at 2:04 PMNew COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Boosterfinance.yahoo.com - February 5 at 9:34 AMAre CSL shares set for an earnings boost?fool.com.au - January 29 at 12:55 AMIs now the right time to buy CSL shares? Here's my takefool.com.au - January 23 at 8:45 PMAll hands on deck for employee growth at CSLtheglobeandmail.com - January 23 at 10:45 AMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ansell (OtherANSLF) and CSL (OtherCMXHF)markets.businessinsider.com - January 14 at 2:26 PMCSL Behring Announces Availability of Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid) 10g Prefilled Syringefinanznachrichten.de - January 3 at 10:37 AMLoop Capital Markets Keeps Their Buy Rating on Carlisle Companies (CSL)markets.businessinsider.com - January 2 at 11:07 PMCSL worker held for 'spying' on Navy shipmsn.com - December 21 at 6:01 PMQURE Jan 2024 25.000 callca.finance.yahoo.com - December 18 at 7:27 AMQURE Jan 2024 5.000 callca.finance.yahoo.com - December 17 at 10:37 AMQURE Jan 2024 25.000 putca.finance.yahoo.com - December 17 at 10:37 AMQURE Jan 2024 9.000 callca.finance.yahoo.com - December 16 at 8:49 PMQURE Jan 2024 9.000 putca.finance.yahoo.com - December 16 at 8:49 PMBMW E46 Owners: Don’t Sleep on Vorsteiner’s Carbon M3 CSL Body Kitmsn.com - December 14 at 3:51 PMCSL's Garadacimab, a First-in-Class Factor XIIa Inhibitor, Receives FDA and EMA Filing Acceptancefinance.yahoo.com - December 14 at 3:51 PMHedge funds divided on CSL as Perpetual and Pendal place opposing betsafr.com - December 4 at 2:52 PMArcturus, CSL win approval for world’s first self-amplifying mRNA vaccine in Japanmsn.com - November 28 at 5:41 PMThese aftermarket carbon bits can make your E46 BMW M3 look like a CSLmsn.com - November 28 at 2:40 AMCan CSL shares reach $300 by Christmas?fool.com.au - November 16 at 6:32 PMHealth Canada Authorizes CSL's HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia Bca.finance.yahoo.com - October 26 at 3:22 PMHow CSL’s new CEO stacks up against Brian McNamee and Paul Perreaultafr.com - October 26 at 3:22 PMWill I look back and regret not buying CSL shares at $237 today?fool.com.au - October 18 at 1:38 AMCSL (CMXHF) Gets a Buy from Macquariemarkets.businessinsider.com - October 16 at 11:37 PMCSL sees greying population as saviour in Ozempic battleafr.com - October 16 at 8:16 AMWhy Ozempic shouldn't ruin an appetite for CSL sharesfool.com.au - October 15 at 10:17 PMCSL boss insists Ozempic won’t slim growthafr.com - October 15 at 10:17 PM Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> CSLLY Media Mentions By Week CSLLY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSLLY News Sentiment▼0.030.33▲Average Medical News Sentiment CSLLY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSLLY Articles This Week▼32▲CSLLY Articles Average Week Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GSK News Today BMY News Today REGN News Today ZTS News Today VRTX News Today SNY News Today TAK News Today PFE News Today ABT News Today NVS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CSLLY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve GoldMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
